Skip to main content

Palbociclib and Diarrhea: What Users Say

Brand names: Ibrance

Diarrhea: mentioned by 5 users (5.0%)

Based on user experiences from 101 Palbociclib reviews, the following table shows the most commonly mentioned side effects.

All user comments are moderated by Drugs.com. Each review is verified for relevance and screened for inappropriate content. Side effects are user-reported and not clinically verified.

fatigue 12.9%
tiredness 10.9%
hair loss 8.9%
loss of appetite 5.9%
nausea 5.9%
diarrhea 5.0%
weakness 5.0%
blood issues 4.0%
joint pain 4.0%
mouth sores 4.0%

Reviews for Palbociclib

  • Onl...
  • September 20, 2015

Palbociclib for Breast Cancer, Metastatic "I am still in treatment, but my initial impression of Ibrance is positive. My doctor is extremely supportive of its uses and anticipated outcomes. (I have a fantastic doctor) I've had ease of access, when I mention Ibrance to medical professionals and the like, their response is positive according to what they're hearing. My side effects have been few and not severe. The only major reaction I experienced was during the course of undergoing radiation treatments and taking Ibrance & Femara in combination. I became neutropenic, with mild diarrhea, weakness, dehydration, and throat and esophagus challenges. My challenges were a bit overwhelming. The newness of Ibrance concerns me. Just hoping it does the job! Thank you."

8 / 10
Was this helpful?YesNo
78 Report
  • Cle...
  • Taken for less than 1 month
  • April 18, 2017

Palbociclib for Breast Cancer, Metastatic "My mother has stage 4 breast cancer with metastatic bone lesions. The oncologist put her on Ibrance, but she developed neutropenia (low white cell count) and caught viral pneumonia. She has had nausea and diarrhea for the past 3 weeks, and we are sitting in the ER right now. Tried all anti-nausea meds, and none have worked. It was a cascading effect of Ibrance, and so she decided she is off all pills. The oncologist washed his hands of her when she said no more Ibrance."

1 / 10
Was this helpful?YesNo
42 Report
  • Can...
  • Taken for 1 to 6 months
  • December 9, 2020

Palbociclib for Breast Cancer, Metastatic "Was on Ibrance and Letrozole for 3 months, possibly the worst of my life. Could not complete 1 single cycle (started 3 in total). White cells nosedived after 15 days. Side effects included mouth ulcers, diarrhea, skin peeling on my fingers and feet soles, extreme fatigue, joint pains. After 3 months, recurrence in axillary lymph nodes + bone lesions. Going back now to chemo. Almost happy about that since it means the end of Ibrance."

1 / 10
Was this helpful?YesNo
5 Report

See also:

Frequently asked questions

  • Lag...
  • Taken for less than 1 month
  • November 22, 2019

For Breast Cancer, Metastatic "My mother had metastatic breast cancer. It was in her lungs, spine, and pelvis. It was also ER/PR positive and HER2 negative. We wanted her to have the best treatment. We had to import Ibrance for her to use at great cost to us, her children. Also, she was on letrozole and denosumab injections for her bones. The Ibrance did nothing for her. Within a month, her cancer markers tripled, the cancer spread more, she was having diarrhea constantly, extreme fatigue, neutropenia, low WBC, low platelets. Within a month of diagnosis of her cancer and using Ibrance, she died from septic shock and febrile neutropenia. The drug did not help her. We could still have had more years with her without using this cursed drug. So, so sad and heartbreaking. We were feeding her poison, we just did not know."

1 / 10
Was this helpful?YesNo
7 Report
  • Bob...
  • Taken for 1 to 6 months
  • December 29, 2019

Palbociclib for Liposarcoma "This medicine gave me horrible diarrhea and dehydrated me. Never will I take this medication again."

2 / 10
Was this helpful?YesNo
11 Report

Are you taking this medicine?

Your review helps others make informed decisions.
Write a review
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.